Trial NCT04758273, ChiCTR2000038804
Publication Pan HX, Chin Med J, 2021
Primary outcome on the report: Adverse reactions or AEs within 28 days following the administration of each vaccine dose

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.